Skip to main content

Hormone Receptor Negative Tumor clinical trials at UCSF

1 research study open to eligible people

Hormone Receptor Negative Tumors are a type of breast cancer that do not respond to hormone therapy. UCSF is currently recruiting for a clinical trial called "I-SPY TRIAL" that aims to discover which new drug agents are most effective in treating this type of tumor. The trial is focused on personalized medicine and testing novel treatments.

Showing trials for
  • I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    open to eligible people ages 18 years and up

    The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

    San Francisco, California and other locations

Last updated: